Chieti, Italy - A variant of the COX-2 gene has been found that is associated with a decreased risk of MI and stroke [1]. The authors of the study claim that a test for this polymorphism, which has ...
Population-based pathogenic variant testing identified breast cancer susceptibility gene carriers who would often be missed ...
Despite global vaccination efforts, COVID-19 continues to pose significant risks, leading to severe complications and fatalities. These risks are driven by disrupted coagulation, impaired fibrinolysis ...
Genetic testing can help doctors diagnose some neurological disorders, such as Huntington’s disease. It can also provide insights into a person’s risk of future health conditions. Genetic testing ...
Genomic medicine leverages an individual’s genetic information to guide healthcare decisions, with drug-gene testing (also known as pharmacogenomics, or PGx) being a key application that personalizes ...
Demand for germline hereditary cancer genetic testing has increased because of reduced cost, gene discovery, expanding indications, and precision cancer therapies. The traditional model for germline ...
Medicare Part B covers various genetic tests for diagnosing genetic conditions, identifying cancer risks, and predicting medication responses if a doctor deems them medically necessary. The cost of ...
Genetic testing for ATTR can detect transthyretin mutations and offer crucial information about risk, monitoring, and treatment, if needed. Transthyretin amyloidosis (ATTR) is a genetic condition that ...
Depression is a highly common mental health condition that affects millions of people worldwide. Medical professionals have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results